
Spinal muscular atrophy, often abbreviated to SMA, is a genetic disease which impacts the nerve cells connecting the brain and spinal cord to the body’s muscles. Due to deterioration of the link between these nerves and muscles, physical activity becomes progressively difficult, as the muscles begin to weaken and shrink.
- Type I SMA – This is the most common and severe form of the disease, which manifests itself during the first six months of an infant’s life. In these cases, complications include severe muscle weakness, breathing problems and trouble swallowing. Due to the severity of type I SMA, also know as Werding-Hoffmann disease, sufferers rarely live past 2 years old.
- Type II SMA – This form of SMA is usually detected at a later stage than type I, usually between the ages of 7-18 months, and is often identified by failings to meet expected motor milestones. While type II does cause serious mobility issues, which will require the affected individuals to use a wheelchair, the majority of sufferers will enjoy long lives, without any additional impairments.
- Type III SMA – While this type is often diagnosed between the ages of 18 months and 3 years, it is possible that the condition will not be identified until the individual’s teenage years, depending on the extent of their ability to walk independently. As they grow, individuals with type III SMA, otherwise known as Kugelberg-Welander disease, may find that their mobility becomes increasingly limited as they age.
- Type IV SMA – This is the most rare form of SMA, which manifests itself during adulthood, usually in individuals aged 35 or more. In these cases, the disease progresses very gradually, leading to mild motor impairment.
























